GTMB 7 - Gene Therapy & Molecular Biology

More documents

Recommendations

Info

George et al: Gene therapy for vascular diseasesLin K.F, Chao J, Chao L (1999) Atrial natriuretic peptide genedelivery reduces stroke-induced mortality rate in Dahl saltsensitiverats. Hypertension 33, 219-224.Loeb J.E, Cordier W, Harris M.E, Weitzman M, Hope T (1999)Enhanced expression of transgenes from adeno-associatedvirus vectors with the woodchuck hepatitis virusposttranscriptional regulatory element: implications for genetherapy. Hum Gene Ther 10, 2295-305.Losordo D, Vale P.R, Symes J.F, Dunnington C, Esakof D.D,Maysky, M, Ashare A.B, Lathi K, Isner J (1998) Genetherapy for myocardial angiogenesis - Initial clinical resultswith direct myocardial injection of phVEGF (165) as soletherapy for myocardial ischemia. Circulation 98, 2800-2804.Lu L, Bonham, CA, Chambers F, Watkins S Hoffman RA,Simmonds R, Thomson A (1996) Induction of nitric oxidesynthase in mouse dendritic cells by IFN-gamma endotoxinand interaction with allogeneic T Cells. Immunology 157,3577-3586.Lundstrom, K, Schweitzer C, Rotmann D, Hermann D,Schneider E, Ehrengruber M (2001) Semliki forest virusvectors: efficient vehicles for in vitro and in vivo genedelivery. FEBS Letters 504, 99 - 103.Luo Z, Sato M, Nguyen T, Kaplan J, Akita G, Walsh, K (1999)Adenovirus-mediated delivery of fas ligand inhibits intimalhyperplasia after balloon injury in immunologically primedanimals. Circulation 99, 1776-1779.Maeda Y, Ikeda U, Ogasawara Y, Urabe M, Takizawa T, SaitoT, Colosi T, Kurtzman G, Shimada K, Ozawa K (1997) Genetransfer into vascular cells using adeno-associated virus(AAV) vectors. Cardiovasc Res 35, 514-521.Maillard L, Van Belle E, Smith, R, Le Roux, A, Denefle P, StegG, Barry, J, Branellec D, Isner J, Walsh, K (1997)Percutaneous delivery of the gax gene inhibits vessel stenosisin a rabbit model of balloon angioplasty. Cardiovasc Res 35,536-546.Makinen K, Manninen H, Hedman M, Matsi P, Mussalo H,Alhava E, Yla-Herttuala S (2002) Increased vascularitydetected by digital subtraction angiography after VEGF genetransfer to human lower limb artery: a randomized placebocontrolleddoubl-blinded phase II study. Mol Ther 6, 127-133.Mann M, Gibbons G, Kernoff R, Diet F, Tsao P, Cooke J,Kaneda Y, Dzau V (1995) Genetic engineering of vein graftsresistant to atherosclerosis. Proc Natl Acad Sci USA 92,4502-4506.Mann M, Whittemore A.D, Donaldson M Belkin M, Conte M,Polak, J.F, Orav, E, Ehsan A, Dell'Acqua G, Dzau V (1999)Ex-vivo gene therapy of human vascular bypass grafts withE2F decoy: the PREVENT single-centre randomisedcontrolled trial. Lancet 354, 1493-1498.Manninen H, Makinen K (2002) Gene therapy techniques forperipheral arterial disease. Cardiovasc Intervent Radiol 25,98-108.Martens J.R, Reaves P.Y, Lu D (1998) Prevention ofrenovascular and cardiac pathophysiological changes inhypertension by angiotensin II type 1 receptor antisense geetherapy. Proc Natl Acad Sci USA 95, 2664-2669.Matsumoto T, Komori K, Yonemitsu Y, Morishita R, Sueishi K,Kaneda Y, Sugimachi K (1998) Hemagglutinating virus ofJapan-liposome-mdiated gene transfer of endothelial cellnitric oxide synthase inhibits intimal hyperplasia of caninegrafts under conditions of poor runoff. J Vasc Surg 27, 135-144.Mintz, G, Popma J, Pichard A, Kent K, Satler L, Wong C.Y,Hong M, Kovach, J, Leon M (1996) Arterial remodelingafter coronary angioplasty: a serial intravascular ultrasoundstudy. Circulation 94, 35-43.Morishita R, Gibbons G, Kaneda Y, Ogihara T, Dzau V (1994)Pharmacokinetics of antisense oliogdeoxyribonucleotides(cyclin B1 and CDC 2 kinase) in the vessel wall in vivo:enhanced therapeutic utility for restenosis by HVJ-liposomedelivery. Gene 149, 13-19.Morishita R, Gibbons G, Horiuchi M, Ellison K, Nakama M,Zhang L, Kaneda Y, Ogihara T, Dzau V (1995) A genetherapy strategy using a transcription factor decoy of the E2Fbinding site inhibits smooth muscle proliferation in vivo.Proc Natl Acad Sci USA 92, 5855-5859.Nabel E, Shum, L, Pompili V, Yang ZY, San H, Shu H.B,Liptay, S, Gold L, Gordon D, Derynck, R (1993) Directtransfer of transforming growth factor b1 gene into arteriesstimulates fibrocellular hyperplasia. Proc Natl Acad SciUSA 90, 10759-10763.Nabel E, Yang Z, Liptay, S, San H, Gordon D, Haudenschild CNabel G (1993a) Recombinant platelet-derived growth factorB expression in porcine arteries induces intimal hyperplasiain vivo. J Clin Invest 91, 1822-1829.Nabel E, Yang Z, Plautz, G, Forough, R, Zhan X, HaudenschildC Maciag T, Nabel G (1993b) Recombinant fibroblastgrowth factor-1 promotes intimal hyperplasia andangiogenesis in arteries in vivo. Nature 362, 844-846.Nakai H, Yant S, Storm, T, Fuess S, Meuse L, Kay, M (2001)Extrachromosomal recombinant adeno-associated virusvector genomes are primarily resposible for stable livertransduction in vivo. Virology 75, 6969 - 6976.Nakamura T, Morishita R, Asai T, Tsuboniwa N, Aoki M,Sakonjo H, Yamasaki K, Hashiya N, Kaneda Y, Ogihara T(2002) Molecular strategy using cis-element 'decoy' of E2Fbinding site inhibits neointimal formation in porcine ballooninjuredcoronary artery model. Gene Ther 9, 488-494.Napoli C (2002) MMP-inhibition and the development ofcerebrovascular atherosclerosis: the road ahead. Stroke 33,2864-2865.Newby A, George S (1996) Proliferation migration matrixturnover and death of smooth muscle cells in native coronaryand vein graft atherosclerosis. Curr Opin Cardiol 11, 574-582.Newman K.D, Dunn P.F, Owens J, Schulick A, Virmani R,Sukhova G, Libby, P, Dichek, D (1995) Adenovirusmediatedgene transfer into normal rabbit arteries results inprolonged vascular cell activation inflammation andneointimal hyperplasia. J Clin Invest 96, 2955-2965.Nicklin SA, Von Seggern D, Work, L, Pek, D.C.K, Dominiczak,A.F, Nemerow, G, Baker A (2001) Ablating adenovirus type5 fiber-CAR binding and HI loop insertion of the SIGYPLPpeptide generate an endothelial cell-selective adenovirus.Mol Ther 4, 534-542.Nishida T, Ueno H, Atsuchi N, Kawano R, Asada Y, NakaharaY, Kamikubo Y, Takeshita A, Yasui H (1999) Adenovirusmediatedlocal expression of human tissue factor pathwayinhibitor eliminates shear stress-induced redurrentthrombosis in the injured carotid artery of the rabbit. CircRes 84, 1446-1452.Noiseux, n, boucher C, Cartier R, Sirois M (2000) Bolusendovascular PDGFR-beta antisense treatment suppressedintimal hyperplasia in a rat carotid injury model. Circulation102 (11), 1330-1336.148
Gene Therapy and Molecular Biology Vol 7, page 149Ohno N, Itoh, H, Ikeda T, Ueyama K, Yamahara K, Doi K,Yamashita J, Inoue M, Masatsugu K, Sawada N, FukunagaY, Sakaguchi S, Sone M, Yurugi T, Kook, H, Komeda M,Nakano K (2002) Accelerated reendothelialization withsuppressed thrombogenic property and neointimalhyperplasia of rabbit jugular vein grafts by adenovirusmediatedgene transfer of C-type natriuretic peptide.Circulation 105, 1623-1626.Parkes R, Meng Q, Siapati K, McEwan J, Hart S (2002) Highefficiency transfection of porcine vascular cells in vitro witha synthetic vector system. J. Gene Medicine 4, 292-299.Parks R, Chen L, Anton M, Sankar U, Rudnicki M, Graham, F(1996) A helper-dependent adenovirus vector system:Removal of helper virus by Cre-mediated excision of theviral packaging signal. Proc Natl Acad Sci USA 93 (24),13565-13570.Phillips M.I (2001) Gene therapy for Hypertension: ThePreclinical Data. Hypertension 38, 543-548.Qing K, Mah, C, Hansen J, Zhou S, Dwarki V, Srivastava A(1999) Human fibroblast growth factor receptor 1 is a coreceptorfor infection by adeno-associated virus 2. Nat Med5, 71-7.Quax, PA, Lamfers M, Grimbergen J, Verheijen J, vanHinsbergh, V (1997) Inhibition of neointima formation incultured human saphenous vein segments by an advenovirusexpressing an urokinase receptor binding plasmin inhibitor.Circulation 96 (Suppl), I-669.Rajagopalan S, Shah, M, Luciano A, Crystal R, Nabel E (2001)Adenovirus-mediated gene transfer of VEGF121 improveslower extremity endothelial function and flow reserve.Circulation 104, 753-755.Rajagopalan S, Mohler E, Lederman R, Saucedo J, MendelsohnF, Olin J, Bleba J, Goldman C, Trachtenberg J, Pressler M,Rasmussen H, Annex, B, Hirsch, A, trial R W.V.E.G.F(2003) Regional angiogenesis with vascular endothelialgrowth factor (VEGF) in peripheral arterial disease: Designof the RAVE trial. Am Heart J 145, 1114-8.Reaves P.Y, Gelband C, Wang H, Yang H, Lu D, Berecek, K,Katovitch, M, Raizada M.K (1999) Permanentcardiovascular protection from hypertension by the AT1receptor antisense gene therapy in hypertensive rat offspring.Circ Res 85, e45-e50.Richter M, Iwata A, Nyhuis J, Nitta Y, Miller A, Halbert L,Allen M (2000) Adeno-associated virus vector transductionof vascular smooth muscle cells in vivo. Physiol. Genomics2, 117-127.Rissanen T, Vajanto I, Yla-Herttuala S (2001) Gene therapy fortherapeutic angiogenesis in critically ischaemic lower limb -on the way to the clinic. Eur J Clin Invest 31, 651-666.Rivard A, Silver M, Chen D, Kearney, M, Magner M, Annex, B,Peters K, Isner J (1999) Rescue of diabetes-relatedimpairment of angiogensis by intramuscular gene therapywith adeno-VEGF. Am J Pathol 154, 355-363.Rosengart T.K, Lee L.Y, Patel S.R, Sanborn TA, Parikh, M,Bergman G, Hachamovitch, R, Szulc M, Kligfield P.D, OkinP, Hahn R Devereux, R.B, Post M.R, Hackett N.R, Foster T,Grasso T, Lesser M, Isom, O, Crystal R (1999) AngiogenesisGene Therapy - Phase I assessment of direct intramyocardialadministration of an adenovirus vector expressing VEGF121cDNA to individuals with clinically significant severecoronary artery disease. Circulation 100, 468-474.Schnepp, B, Clark, K, Klemanski D, Pacak, C, Johnson P (2003)Genetic fate of recombinant adeno-associated virus vectorgenomes in muscle. J Virol 77, 3495-3504.Serruys P, Degertekin M, Tanabe K, Abizaid A, Sousa J.E,Colombo A, Guagliumi G, Wijns W, Lindeboom, W,Ligthart J, de Feyter P, Morice M, Group, R (2002)Intravascular ultrasound findings in the multicenterrandomized double-blind RAVEL (RAndomized study withthe sirolimus-eluting VElocity balloo-expandable stent in thetreatment of patients with de novo native coronary arteryLesions) trial. Circulation 106, 798-803.Shears L, Kibbe M, Murdock, A, Billiar T, Lizonova A, KovesdiI, Watkins S, Tzeng E (1998) Efficient inhibition of intimalhyperplasia by adenovirus-mediated inducible nitric oxidesynthase gene transfer to rats and pigs in vivo. J Am CollSurg 187, 295-306.Shi Y, Fard A, Galeo A, Hutchinson H, Vermani P, Dodge G,Hall D, Shaheen F, Zalewski A (1994) Transcatheter deliveryof c-myc antisense oligomers reduces neointimal formationin a porcine model of coronary artery balloon injury.Circulation 90, 944-951.Shi Y, Patel S, Davenpeck, K, Niculescu R, Rodriguez, E,Magno M, Ormont M, Mannion J, Zalewski A (2001)Oxidative stress and lipid retention in vascular grafts:comparison between venous and arterial conduits.Circulation 15 (103), 19.Shyu K, Manor O, Magner M, Yancopoulos G, Isner J (1998)Direct intramuscular injection of plasmid DNA encodingangiopoietin-1 but not angiopoietin-2 augmentsrevascularization in the rabbit ischemic hindlimb.Circulation 98, 2081-2087.Simari R.D, San H, Rekhter M, Ohno T, Gordon D, Nabel G,Nabel E (1996) Regulation of cellular proliferation andintimal formation following balloon injury in atheroscleroticrabbit arteries. J Clin Invest 98, 225-235.Simons M, Edelman E.R, DeKeyser J.-L, Langer R, Rosenberg R(1992) Antisense c-myb oligonucleotides inhibit intimalarterial smooth muscle cell accumulation in vivo. Nature359, 67-70.Simovic D, Isner J, Ropper A, Pieczek, A, Weinberg D (2001)Improvement in chronic ischemic neuropathy afterintramuscular phVEGF165 gene transfer in patients withcritical limb ischemia. Arch Neurol 58, 761-768.Sirois M, Simons M, Edelman E (1997) Antisenseoligonucleotide inhibition of PDGFR-beta receptor subunitexpression directs suppression of intimal thickening.Circulation 95, 669-676.Smith, R, Branellec D, Gorski D, Guo K, Perlman H, Dedieu J,Pastore C, Mahfoudi A, Denefle P, Isner J, Walsh, K (1997)p21CIP1-mediated inhibition of cell proliferation byoverexpression of gax homeodomain gene. Genes Dev 11,1674-1689.Somia N, Verma I (2000) Gene therapy: trials and tribulations.Nat Rev Genet 1, 1-9.SoRelle R (2001) Late-breaking clinical trials at the AmericanHeart Association's Scientific Session 2001. Circulation104, c9046.Sousa J.E, Costa MA, Sousa A, Abizaid A, Seixas A, Abizaid A,Feres F, Mattos L, Falotico R, Jaeger J, Popma J, Serruys P(2003) Two-year angiographic and intravascular ultrasoundfollow-up after implantation of sirolimus-eluting stents inhuman coronary arteries. Circulation 107, 381-383.Southgate K, Mehta D, Izzat M.B, Newby, A, Angelini G (1999)Increased secretion of basement membrane-degradingmetalloproteinases in pig saphenous vein into carotid arteryinterposition grafts. Arterioscler Thromb Vasc Biol 19,1640-1649.149
Page 7 and 8:
Instructions to authors:Gene Therap
Page 9:
Please submit an electronic version
Page 12:
103-111 ResearchArticle113-133 Revi
Page 17 and 18:
Gene Therapy and Molecular Biology
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77:
Page 80 and 81:
Epperly et al: Late injection of Mn
Page 82 and 83:
Epperly et al: Late injection of Mn
Page 84 and 85:
Goldberg-Cohen et al: Regulation of
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Gascón-Irún et al: Gene therapy a
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Suzuki et al: Regulation of the Sp/
Page 108 and 109:
Page 110 and 111:
Page 112 and 113: Suzuki et al: Regulation of the Sp/
Page 114 and 115: Li et al: MET amplification in live
Page 116 and 117: Li et al: MET amplification in live
Page 118 and 119: Chavakis et al: Leukocyte adhesion
Page 128 and 129: Sanlioglu et al: Adenovirus mediate
Page 150 and 151: George et al: Gene therapy for vasc
Page 168 and 169: Zhang et al: Angiogenic Gene Therap
Page 182 and 183: Xu et al: G-CSF receptor-mediated S
Page 188 and 189: Burek et al: Calcium induced cell d
Page 196 and 197: David et al: Current status and fut
Page 212 and 213:
David et al: Current status and fut
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Stoll et al: The role of EBV and ge
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Maruyama et al: Kidney-targeted pla
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Kren et al: Hepatocyte-targeted del
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Zeng: PRL-3 as a target for cancer
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Latchman: Protective effect of heat
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Cai et al: Lung cancer gene therapy
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309:
show all

GTMB 7 - Gene Therapy & Molecular Biology

Create successful ePaper yourself

Delete template?

Save as template?